Business Insights

Welcome to What Tech Can Do, the podcast series from Roland Berger's Advanced Technology Center that provides insights into technological and industrial shifts and helps build the foundation for successful business strategies based on operational realities.

The conversation goes beyond headline numbers to explain why the recent slowdown in charge point rollout does not signal a cooling market, but a strategic shift toward fewer but faster and smarter chargers. From aging grid infrastructure and disciplined investment to the rise of Chinese OEMs and battery innovation, the episode offers practical insights into managing the risks and opportunities shaping the next phase of e-mobility.

Discover how global competition is evolving, why European and US players face mounting pressure, and what it takes to close the gap to the world's most advanced charging markets.

For more information, visit our website at https://www.rolandberger.com/en/Insights/Podcasts/

Welcome to What Tech Can Do, the podcast series from Roland Berger's Advanced Technology Center that provides insights into technological and industrial shifts and helps build the foundation for successful business strategies based on operational realities.

In this first episode, Junhyuk Choi, Senior Project Manager at Alexec (a Roland Berger company), is joined by Idriss Alami, Managing Partner at Alexec, and Wolfgang Bernhart, Senior Partner and Co-Head of the Advanced Technology Center at Roland Berger, to discuss the realities of scaling battery production in gigafactories. They

In this episode, our partner Florian Dehne, Global Head Aviation, speaks with Martin Gauss, long-time CEO of Air Baltic and since November CEO of Gulf Air, about his fascinating journey from pilot to airline leader – and the lessons he’s learned along the way. Together, they explore how artificial intelligence, digitalization, and simplicity are reshaping the aviation industry.

In this episode, Atlas Air’s Richard Broekman and Katherine Preston join our expert Nikhil Sachdeva to discuss how the air cargo industry is moving forward with decarbonization, even amid geopolitical and market disruptions.

The conversation covers Atlas Air’s targets, its investments in sustainable aviation fuel, fleet modernization, and operational efficiency. As the sector faces both regulatory complexity and supply chain volatility, the focus is shifting from long-term ambition to actionable progress. What role will air cargo play in enabling greener global trade?

For more information, visit our website at rolandberger.com.

In this episode on the future of healthcare, our partner Thilo Kaltenbach speaks with Prof. Dr. med. Harald HHW Schmidt about the rise of network pharmacology and its potential to transform pharmaceutical research and development. The conversation explores how moving beyond organ-based definitions of disease could enable a step change in treating root causes rather than symptoms.

In this episode, our partners Thilo Kaltenbach and Karsten Neumann explore the rapidly evolving landscape of AI in healthcare. It is pretty clear that AI is transforming our lives and all industries. However, how does it play out in the highly regulated healthcare market? Is it more revolution or evolution? From early diagnosis to personalized medicine, AI-powered hospitals and workforce changes, the topic highlights the tangible impacts of AI on patients, physicians, and organizations. With executives aware of AI's potential but facing readiness gaps, key strategic moves need to be executed to stay ahead in this fast-moving field.

In this episode, biologist, TV anchor, and staYoung founder Nina Ruge joins our partner Thilo Kaltenbach to explore the increasing focus on life expectancy and health span. Both have risen significantly over the past century, and new medicines and nutritional supplements are now shaping the next phase of the market for healthy aging.

In this episode, our experts Thilo Kaltenbach and Marina Gilic discuss the growing importance of Environmental, Social, and Governance (ESG) in the MedTech industry. As regulations evolve and customer expectations shift, companies must meet increasing demands for sustainability, patient access, and governance compliance.

In the first episode of our Business Insights series on Health topics, our experts Thilo Kaltenbach and Stephan Fath explore the critical issue of drug availability and the challenges facing pharmaceutical supply chains. Rising global demand, geopolitical tensions, and evolving regulations have created significant disruptions, particularly for essential medicines.

In this episode, our partners Ruirui Zong-Rühe and Beate Rosenthal explore pressing topics within sustainability, its current challenges, and the critical role of industry collaboration in driving higher value. Through examples from two sectors - FMCG (B2C) and chemicals (B2B) - they illustrate a new phase of sustainability marked by three defining factors: heightened regulation, geopolitical influences, and comprehensive business integration led by ESG-mature front runners.

For more information, visit our website at rolandberger.com.